RVPH

RVPH

USD

Reviva Pharmaceuticals Holdings Inc. Common Stock

$0.553-0.017 (-2.982%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$0.570

Hoch

$0.595

Tief

$0.530

Volumen

5.53M

Unternehmensfundamentaldaten

Marktkapitalisierung

53.3M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

9.52M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.25Aktuell $0.553Hoch $4.28

Ähnliche Nachrichten

Analyst Upgrades

D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $2 Price Target

D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals with a Buy and maintains $2 price target.

Mehr anzeigen
D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $2 Price Target
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Reviva Pharmaceuticals, Lowers Price Target to $4

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Reviva Pharmaceuticals with a Buy and lowers the price target from $11 to $4.

Mehr anzeigen
HC Wainwright & Co. Maintains Buy on Reviva Pharmaceuticals, Lowers Price Target to $4
GlobeNewswire

Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners

CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet

Mehr anzeigen
Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.